Idexx Laboratories Inc /De
IDXX · Nasdaq · United States · Health Care · HC Equipment & Services
- Coverage
- FY2016–FY2025
- History
- 10 years
- Latest filing
- 10-K · SEC EDGAR
- Reporting
- USD
- Fiscal year end
- December
- Last updated
- Feb 2026
Headline figures
Idexx Laboratories Inc /De at a glance
In FY2025, Idexx Laboratories Inc /De reported revenue of USD 4,303,702 thousands, EBITDA of USD 1,505,214 thousands, EBITDA margin of 35.0%.
| USD thousands | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | 3,897,504 | 4,303,702 | |||
| EBITDA | 1,258,273 | 1,505,214 | |||
| EBITDA margin | 32.3% | 35.0% | |||
| Free cash flow | 808,079 | 1,057,129 | |||
| ROIC | 58.5% | 71.2% |
The full 10-year history, every line item and each formula are in the platform.
In the platform
- Stat Book — normalized and as-reported IS, BS and CF
- Up to 10 years of annual and quarterly history
- Peer benchmarking and the stock screener
- Corporate risk scorecard
- DCF model from the filed inputs
- Tearsheet and live Excel formulas